Weill Cornell Medicine received a $1.5 million grant from the U.S. Department of Defense Prostate Cancer Research Program to develop new approaches for predicting the spread of cancer cells to the bone in men with prostate cancer, using tumor samples taken at early stages of the disease.
The American Cancer Society projects about 35,250 deaths from prostate cancer in the United States in 2024. “Metastases, especially to the bone, is the leading cause of death in men who have prostate...
Read More